// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Comparing pneumonia risk in COPD patients initiating Fixed Dose Combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone

David Price - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

beclometasone dipropionate

Asthma diagnosis and severity assessment, can microRNAs help? A pilot study

Aref Kyyaly - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough

Jaclyn Smith - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sex Differences in Severe Asthma

Adnan Azim - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma

Simon Couillard - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Breathlessness post COVID-19 despite improvement in cardiopulmonary health

Mark Philip Cassar - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

A review of pulmonary sequestration in a district general hospital

Alex Mcclement - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Pulmonary sequestration

N/A

Role of Discharge VTE Assessment in Correct VTE Prophylaxis Prescription

Hsu Myat Noe - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Capnography monitoring of physician-led procedural sedation procedures during respiratory medicine service

Jurgen Herre - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

The effects of acute sore throat and cough on health-related quality of life (HRQOL) in the 2020 US general population

John E. Ware - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A much shorter core outcome set (COS) for measuring the health-related quality of life (HRQOL) effects of common acute respiratory symptoms

John E. Ware - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

IPC use in non-malignant effusions

Richard Davidson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Refractory chylothorax: Midodrine as a novel therapeutic option

Khalil Ur Rehman - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Midodrine

Defining health states with visual analogue scale and Leicester Cough Questionnaire in chronic cough

Peter Siu Pan Cho - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinically meaningful thresholds for change in cough severity visual analogue scale in chronic cough

Peter Siu Pan Cho - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of the COVID -19 pandemic on pleural infections: A multicentre retrospective analysis

Khalil Ur Rehman - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Post-COVID-19 Symptom Burden: What is Long-COVID and how should we manageit?

Dominic L Sykes - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Evaluation of COVID-19 radiological abnormalities at follow-up

Muneer-Ahmed Syed - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

CAT score as a predictor of long term complications of COVID-19

Raminder Aul - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Hospital re-admissions and deaths associated with COVID-19 illness: survival analysis

Zaimah Ali - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Copyright © 2026. QuantiNova All rights reserved